Evidence map›Paper›PMID 29100294›Full record

ArticleOncotarget2017

Novel tropolones induce the unfolded protein response pathway and apoptosis in multiple myeloma cells.

Staci L Haney, Cheryl Allen, Michelle L Varney, Kaitlyn M Dykstra, Eric R Falcone, Sean H Colligan, Qiang Hu, Alyssa M Aldridge, Dennis L Wright, Andrew J Wiemer and 1 more

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Effects of Troponoids on Mitochondrial Function and Cytotoxicity.Antimicrobial agents and chemotherapy · 2022
    Article
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Staci L HaneyDepartment of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA.
Cheryl AllenDepartment of Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA.
Michelle L VarneyDepartment of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA.
Kaitlyn M DykstraDepartment of Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA.
Eric R FalconeDepartment of Pharmaceutical Sciences, University of Connecticut, Storrs, CT, USA.
Sean H ColliganDepartment of Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA.
Qiang HuBiostatistics and Bioinformatics, Roswell Park Cancer Institute, Buffalo, NY, USA.
Alyssa M AldridgeBrown University, Providence, RI, USA.
Dennis L WrightDepartment of Pharmaceutical Sciences, University of Connecticut, Storrs, CT, USA.
Andrew J WiemerDepartment of Pharmaceutical Sciences, University of Connecticut, Storrs, CT, USA.
Sarah A HolsteinDepartment of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA.
Roswell Park Comprehensive Cancer Center · USUniversity of Connecticut · USUniversity of Nebraska Medical Center · USBrown University · US

Funding

Two-Spirit Films in Indigenous Cancer HealthP30CA016056 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI CANDACE S JOHNSON · 1985 to 2026
$116.6M
Summer Research Experiences in Quantitative Cancer Sciences and Emerging TechnologiesR25CA181003 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI PAMELA A HERSHBERGER, Mukund Seshadri · 2014 to 2026
$3.3M
HDAC Inhibitors Inspired by Natural ProductsR21CA162470 · NCI · UNIVERSITY OF CONNECTICUT STORRS · PI WRIGHT, DENNIS L. · 2011 to 2012
$361k
NCI NIH HHS P30 CA016056NCI NIH HHS R21 CA162470
6 · The paper itself

Abstract

Tropolones are small organic compounds with metal-directing moieties. Tropolones inhibit the proliferation of cancer cell lines, possibly through their effects on metalloenzymes such as select histone deacetylases (HDACs). Pan-HDAC inhibitors are therapeutically beneficial in the treatment of multiple myeloma, however there is interest in the use of more selective HDAC inhibitor therapy to minimize adverse side effects. We hypothesized that tropolones might have anti-myeloma activities. To this end, a series of novel α-substituted tropolones were evaluated for effects on multiple myeloma cells. While all tested tropolones showed some level of cytotoxicity, MO-OH-Nap had consistently low IC

Indexed as

apoptosishistone deacetylasemyelomatropoloneunfolded protein response

Identifiers

PMID29100294
PMCPMC5652688
OpenAlexW2625600807

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.